By using our website, you agree to our use of cookies.
-
Products
Products
-
Services
Services
-
Services
- Challenges Challenges
-
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
Challenges
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
- Support Support
-
Regulatory SupportWest Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.Letter of Authorization Form Regulatory SupportKnowledge Center
Whitepapers, bulletins, videos and seminars from the deep expertise of our teams of scientists, regulatory, and researchers.
Support
Regulatory SupportWest Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.Letter of Authorization Form Regulatory SupportKnowledge CenterWhitepapers, bulletins, videos and seminars from the deep expertise of our teams of scientists, regulatory, and researchers.
- Challenges Challenges
-
West Expert Addresses Extractables and Leachables at Symposium in China
Extractables and leachables (E&L) pose a potential risk to patient safety. Both pharmaceutical companies and regulatory agencies have rising concerns regarding E&L, which has led the Center for Drug Evaluation under the China Federal Drug Administration (CFDA) to release a new standard for public comment (December 30, 2016): Technical Guideline for Compatibility Study of Chemicals and Elastomer Closures. The compatibility study discussed therein focused on E&L.
As a world leader in pharmaceutical packaging, West has a rich history and deep understanding of this subject. Last year, in the Pharmaceutical Packaging Regulation and Technical Open Symposium, which was co-organized by West Scientific Affairs and CNPPA (China National Pharmaceutical Packaging Association), Diane Paskiet, Director of Scientific Affairs, shared insights on E&L, as well as suggestions for the China technical guideline.
Diane discussed:
- industry E&L best practices in developed markets
- updates on related USP chapters
- understanding Technical Guideline for Compatibility Study of Chemicals and Elastomer Closures
- CFDA’s extractable requirements for bundling review
- responsibilities of packaging suppliers and pharmaceutical companies
- Product Quality Research Institute (PQRI) safety thresholds
At West, patient safety is the highest priority. For more information on E&L, and how West can design and execute studies to evaluate E&L issues to promote patient safety visit the website, our Knowledge Center, or contact a Technical Customer Support representative.